Quick Answer
Sanara MedTech Inc. reported Operating Income Loss of $7.30 million for the year ending 2025.
- Sanara MedTech Inc. showed an increase of +480.3% in Operating Income Loss from 2024 to 2025.
- This data is from Sanara MedTech Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 11 years of available data (2015 to 2025), Sanara MedTech Inc.'s Operating Income Loss has grown by 857.0%.
- Historical annual values: Fiscal year 2025: $7.30 million | Fiscal year 2024: $1.26 million | Fiscal year 2023: -$4.22 million | Fiscal year 2022: -$12.52 million | Fiscal year 2021: -$7.38 million | Fiscal year 2020: -$5.03 million | Fiscal year 2019: -$2.74 million | Fiscal year 2018: -$501.9 thousand | Fiscal year 2017: $120.4 thousand | Fiscal year 2016: -$272.1 thousand | Fiscal year 2015: -$965.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: